Overview
Carbios is one of the most technically distinctive French industrial biotech companies — a Clermont-Ferrand-based biotechnology company that has developed enzymatic depolymerization technology capable of breaking down PET plastic and polyester textile fibers into their virgin-equivalent monomers for infinite recycling. The technology, developed over a decade in collaboration with INRAE and the Université de Toulouse, uses a thermophilic enzyme (LCCICCG) that breaks the molecular bonds of PET polymers more efficiently than any previously known biological or chemical process, at commercially relevant temperatures and timescales.
Publicly listed on Euronext Growth, Carbios represents France’s deep tech approach to circular economy challenges: rather than incremental improvements to mechanical recycling (which downgrades plastic quality with each cycle) or chemical pyrolysis (which requires high temperatures and produces heterogeneous outputs), Carbios’s enzymatic process converts mixed, colored, and contaminated PET waste into the same monomers (terephthalic acid and monoethylene glycol) that are used to produce virgin PET — enabling truly infinite closed-loop recycling. The company has signed commercial agreements with L’Oréal, Nestlé Waters, PepsiCo, and Solvay, demonstrating genuine industry validation of its technology.
France 2030 Funding & Projects
Carbios is one of the most directly France 2030-funded companies in the bioeconomy and industrial decarbonization sectors. The company received significant support through ADEME’s industrial decarbonization and circular economy programs, and has benefited from Bpifrance’s deeptech innovation competitions, including i-Démo (the flagship Bpifrance competition for breakthrough industrial innovation). France 2030’s industrial decarbonization axis specifically targets bioprocesses as a key pathway for reducing industrial carbon footprint — and Carbios’s enzymatic recycling technology is the clearest example of this approach at commercial scale.
The company has also participated in France 2030’s bioeconomy research programs through its ongoing collaboration with INRAE — France’s national agricultural and environmental research institute, itself a designated France 2030 research partner. France 2030 funds INRAE’s industrial biotech research, creating the academic infrastructure from which companies like Carbios commercialize breakthrough enzymes and processes. The French state’s support for Carbios’s scale-up to commercial biorecycling plants represents a France 2030 success story: research funding translated into globally leading industrial technology.
Strategic Position
Carbios is developing the first commercial-scale enzymatic PET biorecycling plant at Longlaville (Meurthe-et-Moselle) in partnership with Indorama Ventures — the world’s largest PET producer — with a planned capacity of 50,000 tonnes of PET per year. This plant, expected online in 2026, would be the world’s first commercial-scale enzymatic PET recycling facility, establishing Carbios as the market pioneer in a technology segment with no direct competitor at equivalent maturity.
The global PET market produces approximately 82 million tonnes annually — including beverage bottles, food packaging, and polyester clothing. Of this, roughly 15% is mechanically recycled; enzymatic recycling addresses the remaining 85% that currently goes to landfill, incineration, or lower-value mechanical recycling. The addressable opportunity for enzymatic recycling is enormous, though the technology must achieve competitive economics versus virgin PET production — a threshold that carbon pricing and extended producer responsibility legislation is progressively approaching.
Key Technology & Innovation
The LCCICCG enzyme at the core of Carbios’s technology is a leaf-branch compost cutinase variant that was engineered through directed evolution — a process of iterative mutation and selection that mimics natural evolution to optimize enzyme performance. The published scientific results (Nature, 2020) demonstrated depolymerization of 90% of PET in 10 hours at 72°C — a dramatic improvement over previous enzymatic approaches that required days or weeks for similar conversion rates.
Carbios holds extensive patent protection covering the enzyme itself, the depolymerization process conditions, and the downstream purification steps that produce food-grade recycled monomers. This IP portfolio creates barriers to competitive entry that are high but not impenetrable — a determined competitor with similar enzyme engineering capabilities could potentially develop workaround processes, though the Carbios patent landscape is deliberately broad.
Leadership
Emmanuel Ladent serves as CEO, having led Carbios’s commercial and industrial scale-up phase following early-stage research leadership. The company’s Clermont-Ferrand base reflects its connection to the Auvergne-Rhône-Alpes biotech ecosystem and its academic partnerships with Clermont-Ferrand universities. The Indorama Ventures partnership for the commercial plant is the most significant strategic relationship, as Indorama’s PET industry expertise and global customer relationships provide market access that Carbios’s biotech team could not build independently.
Competitive Landscape
Carbios occupies first-mover position in enzymatic PET depolymerization — no commercial competitor has demonstrated equivalent technology at comparable maturity. Chemical depolymerization companies (PureCycle Technologies for PP, Plastic Energy for pyrolysis) address different chemistries and processes. The broader plastic recycling market includes mechanical recyclers and chemical recyclers pursuing higher-temperature processes (pyrolysis, gasification) that are less selective but more tolerant of mixed plastic waste.
Indorama’s entry as a shareholder and commercial partner also reduces competitive threat from within the PET value chain: the world’s largest PET producer has aligned its interests with Carbios’s success rather than pursuing competing technology development.
Investor Perspective
Carbios (Euronext Growth: ALCRB) has a market capitalization of approximately €200–400 million, reflecting the company’s technology leadership and commercial validation alongside the significant capital required to build the first commercial plant. The investment thesis is straightforward: if enzymatic recycling achieves commercial scale at competitive cost, Carbios’s first-mover IP and process know-how position it to license the technology globally, generating recurring royalty revenues from a circular economy sector with regulatory tailwinds.
France 2030’s circular economy and industrial decarbonization support reduces the capital at risk for the Longlaville plant construction while accelerating the market formation that Carbios requires for commercial success. For investors interested in industrial biotech and circular economy, Carbios represents the most advanced French company in enzymatic material recycling.